Resources
Videos
Assessment of plasma preparations in TTP
Prof. Dr. Paul Coppo, MD, CNR-MAT, AP-HP
Hóspital Saint-Antoine
Paris, France
Language: German
Assessment of plasma preparations in TTP
Prof. Dr. Paul Coppo, MD, CNR-MAT, AP-HP
Hóspital Saint-Antoine
Paris, France
Language: English
Bacterial contamination of platelet components, passive vs. active, surveillance, testing and pathogen reduction technologies
Dr. Richard J. Benjamin, MBChB, PhD, FRCPath
Cerus Corporation
Concord, California, USA
Language: English
Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives
Dr. Ryan A. Metcalf
University of Utah and ARUP Laboratories
Utah, USA
Language: English
Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives
Dr. Ryan A. Metcalf
University of Utah and ARUP Laboratories
Utah, USA
Language: German
Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives
Dr. Ryan A. Metcalf
University of Utah and ARUP Laboratories
Utah, USA
Language: Polish
Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives
Dr. Ryan A. Metcalf
University of Utah and ARUP Laboratories
Utah, USA
Language: Spanish
Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives
Dr. Ryan A. Metcalf
University of Utah and ARUP Laboratories
Utah, USA
Language: Russian
Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment
Dr. Laurence M. Corash, M.D.
Cerus Corporation
Concord, California, USA
Language: German
Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment
Dr. Laurence M. Corash, M.D.
Cerus Corporation
Concord, California, USA
Language: Russian
Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment
Dr. Laurence M. Corash, M.D.
Cerus Corporation
Concord, California, USA
Language: Polish
Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment
Dr. Laurence M. Corash, M.D.
Cerus Corporation
Concord, California, USA
Language: Spanish
Bacterial safety of platelet components prepared with Amotosalen-UVA photochemical treatment
Dr. Laurence M. Corash, M.D.
Cerus Corporation
Concord, California, USA
Language: English
Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System
Prof. Salwa Ibrahim Hindawi
King Abdulaziz University
Jeddah, Saudi Arabia
Language: Italian
Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System
Prof. Salwa Ibrahim Hindawi
King Abdulaziz University
Jeddah, Saudi Arabia
Language: Spanish
Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System
Prof. Salwa Ibrahim Hindawi
King Abdulaziz University
Jeddah, Saudi Arabia
Language: German
Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System
Prof. Salwa Ibrahim Hindawi
King Abdulaziz University
Jeddah, Saudi Arabia
Language: English
Case study: enabling double dose methodology on Reveos through pathogen inactivation
Ms. Eleonore Tennby
Cerus Europe B.V.
Amersfoort, the Netherlands
Language: English
Case study: impact of pathogen inactivation on outdating rates and supply continuity
Ms. Ragna Landrö, BSc
The Blood Bank
The National University Hospital of Iceland
Reykjavík, Iceland
Language: English
Clinical performance of INTERCEPT and solvent detergent plasma used with idiopathic thrombotic purpura patients requiring therapeutic plasma exchanges
Dr. Mario Ojeda-Uribe, MD
Groupe Hospitalier Region Mulhouse Sud-Alsace (GHRMSA)
Hospital E. Muller
Mulhouse, France
Language: English
No results found.